Swedbank Robur Healthcare
- Namn
- Swedbank Robur Healthcare
- Fondbolag
- Swedbank Robur Fonder AB
- ISIN
- SE0000639445
- Kvartalsslut
- Fondförmögenhet
- 16 156 678 154 SEK
- Likvida medel
- 631 489 843 SEK
- Övriga tillgångar och skulder
- 1 628 361 SEK
- Antal innehav
- 62
- Aktiv risk
- 4,56
- Standardavvikelse 24 månader
- 13,37
- Jämförelseindex
- MSCI World Health Care 10/40 Net
-
Förvaltningsavgift
Healthcare A - 1,25% Fast
-
Förvaltningsavgift
Healthcare C - 1,25% Fast
Största innehav
| Namn | Marknadsvärde | Andel av fondförmögenhet | Bransch |
|---|---|---|---|
| United Health | 1 406 048 740 SEK | 8,70% | Health Care |
| AstraZeneca | 904 262 006 SEK | 5,60% | Health Care |
| Roche | 863 062 690 SEK | 5,34% | Health Care |
| Thermo Fisher Scientific | 840 068 982 SEK | 5,20% | Health Care |
| Pfizer | 752 181 412 SEK | 4,66% | Health Care |
| Abbott Laboratories | 747 307 214 SEK | 4,63% | Health Care |
| Centene | 680 413 411 SEK | 4,21% | Health Care |
| Merck | 622 515 334 SEK | 3,85% | Health Care |
| Sanofi | 579 622 657 SEK | 3,59% | Health Care |
| Horizon Therapeutics | 511 786 607 SEK | 3,17% | Health Care |
| Amgen | 453 593 613 SEK | 2,81% | Health Care |
| Novo Nordisk | 453 322 624 SEK | 2,81% | Health Care |
| Vertex Pharmaceuticals | 415 122 227 SEK | 2,57% | Health Care |
| Edward Lifesciences | 414 731 491 SEK | 2,57% | Health Care |
| Eli Lilly | 391 437 553 SEK | 2,42% | Health Care |
| Cooper Companies | 371 395 573 SEK | 2,30% | Health Care |
| Takeda | 344 069 101 SEK | 2,13% | Health Care |
| Livanova | 306 994 888 SEK | 1,90% | Health Care |
| Intuitive Surgical | 286 559 723 SEK | 1,77% | Health Care |
| Hologic | 266 018 923 SEK | 1,65% | Health Care |
| Surgical Science Sweden | 260 157 400 SEK | 1,61% | Health Care |
| UCB | 252 055 948 SEK | 1,56% | Health Care |
| Exelixis | 229 468 396 SEK | 1,42% | Health Care |
| IQVIA | 218 308 515 SEK | 1,35% | Health Care |
| AMN Healthcare Services | 207 669 702 SEK | 1,29% | Health Care |
Branscher
Källa: Finansinspektionen.